Skip to main content
Erschienen in: International Urology and Nephrology 7/2018

11.04.2018 | Nephrology - Original Paper

Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis

verfasst von: Patompong Ungprasert, Sukit Raksasuk

Erschienen in: International Urology and Nephrology | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Patients with psoriasis may have a higher risk of developing chronic kidney (CKD) and end-stage renal disease (ESRD) compared with general population. This systematic review and meta-analysis aimed to comprehensively investigate this association by reviewing all available evidence.

Methods

A systematic review was performed using MEDLINE and EMBASE database from inception to January 2018 to identify all cohort studies that compared the risk of incident CKD and/or ESRD in patients with psoriasis versus individuals without psoriasis. Pooled risk ratio and 95% confidence interval were calculated using random-effect, generic inverse variance method.

Results

A total of four retrospective cohort studies with 199,808 patients with psoriasis were included. The risk of incident CKD and ESRD was significantly increased among patients with psoriasis with the pooled risk ratio of 1.34 (95% CI, 1.14–1.57) and 1.29 (95% CI, 1.05–1.60), respectively.

Conclusion

A significantly increased risk of incident CKD and ESRD among patients with psoriasis compared with individuals without psoriasis was demonstrated in this study.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Gisondi P (2017) High prevalence of alcohol use disorders in patients with inflammatory skin diseases applies to both psoriasis and eczema. Br J Dermatol 177:606–607CrossRefPubMed Gisondi P (2017) High prevalence of alcohol use disorders in patients with inflammatory skin diseases applies to both psoriasis and eczema. Br J Dermatol 177:606–607CrossRefPubMed
3.
Zurück zum Zitat Duffy DL, Spelman LS, Martin NG (1993) Psoriasis in Australian twins. J Am Acad Dermatol 29:428–434CrossRefPubMed Duffy DL, Spelman LS, Martin NG (1993) Psoriasis in Australian twins. J Am Acad Dermatol 29:428–434CrossRefPubMed
4.
Zurück zum Zitat Correia B, Torres T (2015) Obesity: a key component of psoriasis. Acta Biomed 86:121–129PubMed Correia B, Torres T (2015) Obesity: a key component of psoriasis. Acta Biomed 86:121–129PubMed
5.
Zurück zum Zitat Naldi L, Mercuri SR (2009) Smoking and psoriasis: from epidemiology to pathomechanism. J Invest Dermatol 129:2741–2743CrossRefPubMed Naldi L, Mercuri SR (2009) Smoking and psoriasis: from epidemiology to pathomechanism. J Invest Dermatol 129:2741–2743CrossRefPubMed
6.
Zurück zum Zitat Kokpol C, Aekplakorn W, Rajatanavin N (2014) Prevalence and characteristics of metabolic syndrome in South-East Asian psoriatic patients: a case-control study. J Dermatol 41:898–902CrossRefPubMed Kokpol C, Aekplakorn W, Rajatanavin N (2014) Prevalence and characteristics of metabolic syndrome in South-East Asian psoriatic patients: a case-control study. J Dermatol 41:898–902CrossRefPubMed
7.
Zurück zum Zitat Ungprasert P, Sanguankeo A, Upala S et al (2014) Psoriasis and venous thromboembolism: a systematic review and meta-analysis. QJM 107:793–797CrossRefPubMed Ungprasert P, Sanguankeo A, Upala S et al (2014) Psoriasis and venous thromboembolism: a systematic review and meta-analysis. QJM 107:793–797CrossRefPubMed
8.
Zurück zum Zitat Ungprasert P, Srivali N, Kittanamongkolchai W (2016) Psoriasis and risk of incident atrial fibrillation: a systematic review and meta-analysis. Indian J Dermatol Venereol Leprol 82:489–497CrossRefPubMed Ungprasert P, Srivali N, Kittanamongkolchai W (2016) Psoriasis and risk of incident atrial fibrillation: a systematic review and meta-analysis. Indian J Dermatol Venereol Leprol 82:489–497CrossRefPubMed
9.
Zurück zum Zitat Bissonnette R, Kerdel F, Naldi L et al (2017) Evaluation of risk of major adverse cardiovascular events with biologic therapy in patients with psoriasis. J Drugs Dermatol 16:1002–1013PubMed Bissonnette R, Kerdel F, Naldi L et al (2017) Evaluation of risk of major adverse cardiovascular events with biologic therapy in patients with psoriasis. J Drugs Dermatol 16:1002–1013PubMed
11.
Zurück zum Zitat Maradit-Kremers H, Nicola PJ, Crowson CS et al (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722–732CrossRefPubMed Maradit-Kremers H, Nicola PJ, Crowson CS et al (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722–732CrossRefPubMed
12.
Zurück zum Zitat Wan J, Wang S, Haynes K et al (2013) Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ 347:f5961CrossRefPubMedPubMedCentral Wan J, Wang S, Haynes K et al (2013) Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ 347:f5961CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Chiu HY, Huang HL, Li CH et al (2015) Increased risk of glomerulonephritis and chronic kidney disease in relation to severity of psoriasis, concomitant medication, and comorbidity: a nation-wide population-based cohort study. Br J Dermatol 173:146–154CrossRefPubMed Chiu HY, Huang HL, Li CH et al (2015) Increased risk of glomerulonephritis and chronic kidney disease in relation to severity of psoriasis, concomitant medication, and comorbidity: a nation-wide population-based cohort study. Br J Dermatol 173:146–154CrossRefPubMed
14.
Zurück zum Zitat Parisi R, Rutter MK, Lunt M et al (2015) Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink. J Invest Dermatol 135:2189–2197CrossRefPubMed Parisi R, Rutter MK, Lunt M et al (2015) Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink. J Invest Dermatol 135:2189–2197CrossRefPubMed
15.
Zurück zum Zitat Yu S, Tu HP, Yu CL et al (2017) Is psoriasis an independent risk factor of renal disease? A nationwide retrospective cohort study from 1996 to 2010. Dermatol Sin 35:78–84CrossRef Yu S, Tu HP, Yu CL et al (2017) Is psoriasis an independent risk factor of renal disease? A nationwide retrospective cohort study from 1996 to 2010. Dermatol Sin 35:78–84CrossRef
16.
Zurück zum Zitat Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605CrossRefPubMed Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605CrossRefPubMed
17.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trial 7:177–188CrossRef DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trial 7:177–188CrossRef
19.
Zurück zum Zitat Ozyilmaz A, de Jong PE, Gansevoort RT (2012) Screening for chronic kidney disease can be of help to prevent atherosclerotic end-organ damage. Nephrol Dial Transplant 27:4046–4052CrossRefPubMed Ozyilmaz A, de Jong PE, Gansevoort RT (2012) Screening for chronic kidney disease can be of help to prevent atherosclerotic end-organ damage. Nephrol Dial Transplant 27:4046–4052CrossRefPubMed
20.
Zurück zum Zitat Shahwan KT, Kimball AB (2015) Psoriasis and cardiovascular disease. Med Clin N Am 99:1227–1242CrossRefPubMed Shahwan KT, Kimball AB (2015) Psoriasis and cardiovascular disease. Med Clin N Am 99:1227–1242CrossRefPubMed
21.
Zurück zum Zitat Ogawa E, Sato Y, Minagawa A et al (2017) Pathogenesis of psoriasis and development of treatment. J Dermatol (epub ahead of pirnt) Ogawa E, Sato Y, Minagawa A et al (2017) Pathogenesis of psoriasis and development of treatment. J Dermatol (epub ahead of pirnt)
22.
Zurück zum Zitat Turner JE, Paust HJ, Steinmetz OM et al (2010) The Th17 immune response in renal inflammation. Kidney Int 77:1070e5CrossRef Turner JE, Paust HJ, Steinmetz OM et al (2010) The Th17 immune response in renal inflammation. Kidney Int 77:1070e5CrossRef
23.
Zurück zum Zitat Kitching AR, Holdsworth SR (2011) The emergence of TH17 cells as effectors of renal injury. J Am Soc Nephrol 22:235e8CrossRef Kitching AR, Holdsworth SR (2011) The emergence of TH17 cells as effectors of renal injury. J Am Soc Nephrol 22:235e8CrossRef
24.
Zurück zum Zitat Imai H, Kodama T, Ishino T et al (1995) IgA nephropathy associated with hyper IgAnemia, psoriasis or pustulosis and ossification. Clin Nephrol 44:64–68PubMed Imai H, Kodama T, Ishino T et al (1995) IgA nephropathy associated with hyper IgAnemia, psoriasis or pustulosis and ossification. Clin Nephrol 44:64–68PubMed
25.
Zurück zum Zitat Zadrazil J, Tichy T, Horak P et al (2006) IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of ‘psoriatic nephropathy’. J Nephrol 19:382–386PubMed Zadrazil J, Tichy T, Horak P et al (2006) IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of ‘psoriatic nephropathy’. J Nephrol 19:382–386PubMed
26.
Zurück zum Zitat Kluger N, Du-Thanh A, Bessis D et al (2015) Psoriasis-associated IgA nephropathy under infliximab therapy. Int J Dermatol 54:e79–e80CrossRefPubMed Kluger N, Du-Thanh A, Bessis D et al (2015) Psoriasis-associated IgA nephropathy under infliximab therapy. Int J Dermatol 54:e79–e80CrossRefPubMed
27.
Zurück zum Zitat Kaji T, Tsukada Y, Shimada A et al (1994) Membranous nephropathy associated with psoriasis vulgaris. Clin Nephrol 42:63–64PubMed Kaji T, Tsukada Y, Shimada A et al (1994) Membranous nephropathy associated with psoriasis vulgaris. Clin Nephrol 42:63–64PubMed
Metadaten
Titel
Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis
verfasst von
Patompong Ungprasert
Sukit Raksasuk
Publikationsdatum
11.04.2018
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 7/2018
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-018-1868-z

Weitere Artikel der Ausgabe 7/2018

International Urology and Nephrology 7/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.